NEWS & PRESENTATIONS

Recent News & Press Releases

March 31, 2020

Incysus Therapeutics to Present at the NYC Spring Oncology Investor Conference

Incysus Therapeutics, Inc. today announced that the Company the Company will present at the 2020 NYC Spring Oncology Investor Conference being held on March 31st and April 1st. William Ho, President and Chief Executive Officer of Incysus Therapeutics, will present a company update. 

February 26, 2020

Incysus Therapeutics Initiates Enrollment in Phase I Study of a Genetically Modified Gamma-Delta (γδ) T Cell Immunotherapy in Patients with Newly-Diagnosed Glioblastoma

Incysus Therapeutics, Inc. today announced that the Company has initiated a Phase 1 clinical study of a novel Drug Resistant Immunotherapy (DRI) technology for the treatment of patients with newly-diagnosed glioblastoma.  This trial is being conducted at the University of Alabama at Birmingham (UAB) and is now active and open for enrollment.

February 7, 2020

Incysus Therapeutics to Present at the 2020 BIO CEO & Investor Conference

Incysus Therapeutics, Inc. today announced that William Ho, President and Chief Executive Officer of Incysus will present at the 2020 BIO CEO & Investor Conference on Monday, February 10, 2020 at 1:15 p.m. Eastern Time.  The Conference will be held at the New York Marriott Marquis hotel on 1535 Broadway in New York City.

January 23, 2020

Incysus Therapeutics Announces Issuance of Foundational U.S. Patent Covering Use of Drug Resistant Immunotherapy (DRI) Technology for the Treatment of Cancer

Incysus Therapeutics, Inc. today announced that the USPTO has issued, U.S. Patent Number 10,543,233 titled “Drug Resistant Immunotherapy for Treatment of a Cancer.”  The patent broadly covers the use of genetic engineering to chemo-protect gamma-delta (γδ) T cells and allow simultaneous chemo-immunotherapy combinations for the treatment of cancer.

January 9, 2020

Incysus Therapeutics to Present at Biotech Showcase 2020

Incysus Therapeutics, Inc. today announced that William Ho, President and Chief Executive Officer of Incysus will present at the Biotech Showcase on Monday, January 13, 2020 at 3:15 p.m. Pacific Time in the Franciscan B Ballroom (Ballroom Level).  The conference will be held at the Hilton San Francisco Union Square, San Francisco, CA.

©2020 by Incysus Therapeutics, Inc.  |  info@incysus.com  |  Privacy Policy  |  Terms of Use